Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia
Anusara Daenthanasanmak(National Institutes of Health), Thomas A. Waldmann(National Institutes of Health)
Cited by 12
Related Papers
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
|Journal of Clinical Oncology|2014|698
Cytokines in Cancer Immunotherapy
|Cold Spring Harbor Perspectives in Biology|2017|509
The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy
|Cancer Immunology Research|2015|236
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity
|Journal of Clinical Investigation|2018|46